• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Accelerant Holdings filed SEC Form 8-K: Leadership Update

    3/18/26 4:10:36 PM ET
    $ARX
    Specialty Insurers
    Finance
    Get the next $ARX alert in real time by email
    8-K
    0001997350 false 0001997350 2026-03-13 2026-03-13
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): March 13, 2026

     

     

    ACCELERANT HOLDINGS

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Cayman Islands   001-42765   98-1753044

    (State or Other Jurisdiction of

    Incorporation or Organization)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification Number)

    Accelerant Holdings

    c/o Accelerant Re (Cayman) Ltd.

    Unit 106, Windward 3, Regatta Office Park,

    West Bay Road, Grand Cayman, KY1-1108

    +1 (345) 743-4611

    (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Securities Act:

     

    Title of Each Class

     

    Trading

    Symbol

     

    Name of Each Exchange

    on Which Registered

    Class A common shares, $0.0000011951862 par value per share   ARX   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

     

     
     


    Item 2.02. Results of Operations and Financial Condition

    On March 18, 2026, Accelerant Holdings (the “Company,” “we,” or “our”) issued a press release relating to our earnings for the quarter and year ended December 31, 2025 (the “Earnings Release”). The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Chief Financial Officer Transition

    On March 18, 2026, Accelerant Holdings (the “Company”) appointed Linda S. Huber as Chief Financial Officer and designated her as the Company’s principal financial officer and principal accounting officer, effective, in each case, on March 31, 2026 (the “Effective Date”). Jay Green will no longer serve as the Company’s Chief Financial Officer, and principal financial officer and principal accounting officer, effective as of the Effective Date.

    Prior to joining the Company, Ms. Huber, age 67, served as Chief Financial Officer of FactSet Research Systems Inc. (NYSE: FDS), MSCI Inc. (NYSE: MSCI), and Moody’s Corporation (NYSE: MCO). Ms. Huber also served on the Board of Directors of the Bank of Montreal (NYSE: BMO), where she was a member of the Audit and Conduct Review Committee and the Risk Review Committee. Most recently, she worked as a strategic advisor to a leading investment management firm identifying investment opportunities in the financial data and analytics industry.

    In connection with Ms. Huber’s appointment, she entered into an employment agreement with the Company on March 18, 2026 (the “Employment Agreement”). Pursuant to the Employment Agreement, Ms. Huber will receive an annualized base salary of $650,000, subject to annual increases based upon review by our compensation committee of the Board of Directors of the Company (the “Compensation Committee”). In addition, pursuant to the Employment Agreement, Ms. Huber is entitled to participate in the Company’s discretionary annual bonus arrangements with a target annual bonus opportunity of $1,053,000, which amount is guaranteed and not subject to performance adjustments with respect to 2026, subject only to Ms. Huber’s continued service through the bonus payment date in 2027. Pursuant to the Employment Agreement, Ms. Huber is also entitled to participate in the equity incentive program maintained for senior executive officers of the Company and its subsidiaries and is to receive a restricted stock unit (“RSU”) award of $2,500,000 in March 2026, which will vest as to twenty-five percent (25%) of the RSUs on the one-year anniversary of the grant date and as to six and one-quarter percent (6-1/4%) of the RSUs on the first day of each of the twelve (12) calendar quarters beginning after such anniversary. The Employment Agreement also provides that Ms. Huber’s annual target equity opportunity shall be $2,000,000 in grant date value, with 50% of such target opportunity delivered in RSUs and 50% delivered in PSUs, subject to approval by the Compensation Committee and the terms of the applicable equity plan and award agreements. She is also entitled to reimbursement of attorneys’ fees arising out of the negotiation of the Employment Agreement up to a maximum of $50,000.

    Under the terms of the Employment Agreement, in the event Ms. Huber is terminated by us without “cause” or she terminates her employment for “good reason,” Ms. Huber would become entitled to receive: (i) an aggregate amount equal to the sum of (A) two times Ms. Huber’s then-current base compensation plus (B) her target annual bonus for the year of termination paid over 12 months; (ii) up to 18 months of reimbursement for COBRA premiums; and (iii) Ms. Huber’s annual bonus for the year prior to the year of termination, if not yet paid (for the

     


    2026 bonus, the amount of $1,053,000) at the time such bonuses are paid to executive officers of the Company. If Ms. Huber’s employment is terminated due to her death or disability, she would be entitled to her pro rata annual bonus for the year of such termination and her annual bonus for the year prior to the year of termination, if not yet paid (for the 2026 bonus, the amount of $1,053,000). In connection with Ms. Huber’s entry into the Employment Agreement, Ms. Huber also entered into a Restrictive Covenant Agreement (the “Restrictive Covenant Agreement”) which subjects Ms. Huber to certain non-competition, non-solicitation and confidentiality provisions.

    The description of the Employment Agreement in this Item 5.02 is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference. The description of the Restrictive Covenant Agreement in this Item 5.02 is qualified in its entirety by reference to the full text of the Restrictive Covenant Agreement, a copy of which is attached hereto as Exhibit 10.2 and incorporated herein by reference.

    There are no arrangements or understandings between Ms. Huber and any other person pursuant to which she was appointed as chief financial officer and designated as principal executive officer and principal accounting officer. Ms. Huber does not have any family relationship with any director or other executive officer of the Company, or any person nominated or chosen by the Company to become a director or executive officer, and there are no transactions in which Ms. Huber has an interest requiring disclosure under Item 404(a) of Regulation S-K currently contemplated or since the beginning of the last fiscal year.

    Mr. Green’s separation from the Company is a termination without “cause” for purposes of Mr. Green’s Amended and Restated Employment Agreement dated November 5, 2025, including for purposes of determining all amounts payable to Mr. Green thereunder in connection with his separation. In connection with Mr. Green’s separation, he entered into a Separation Agreement with the Company dated March 18, 2026 which sets forth the terms of his separation and provides for payment of termination without “cause” benefits under his Amended and Restated Employment Agreement. The description of the Separation Agreement in this Item 5.02 is qualified in its entirety by reference to the full text of the Separation Agreement, a copy of which is attached hereto as Exhibit 10.3 and incorporated herein by reference.

    Board Member Resignation

    On March 13, 2026, Michael Searles informed the Company of his resignation from the Company’s board of directors, effective immediately. Mr. Searles joined the board in June 2023, prior to the Company’s initial public offering, as an appointee of a Company investor. Mr. Searles served as a Class I director, with his term of office set to expire on May 12, 2026, the date of the Company’s Annual General Meeting of Shareholders (the “2026 Annual General Meeting”).

    Item 7.01. Regulation FD Disclosure

    On March 18, 2026, the Company posted a presentation to its website at https://investor.accelerant.ai/. A copy of the presentation is furnished as Exhibit 99.2 to this Report. The Company expects to use the presentation, in whole or in part, and possibly with modifications, in connection with the earnings call with investors, analysts and others.

    The information contained in the presentation is summary information that is intended to be considered in the context of the Company’s Securities and Exchange Commission (“SEC”) filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The presentation speaks only as of the date of this Report. The Company undertakes no duty or obligation to publicly update or revise the information contained in the presentation, although it may do so from time to time. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure. In addition, the exhibit furnished herewith contains statements intended as “forward-looking statements” that are subject to the cautionary statements about forward-looking statements set forth in such exhibit. By furnishing the information contained in the presentation, the Company makes no admission as to the materiality of any information in the presentation that is required to be disclosed solely by reason of Regulation FD.

     


    The information contained in this Items 2.02 and 7.01 of this Report (as well as in Exhibits 99.1 and 99.2 attached hereto) is furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended or the Exchange Act.

    Item 8.01. Other Events

    Approval of Share Repurchase Plan

    On March 18, 2026, the Company’s Board of Directors authorized a share repurchase program to purchase up to $200 million of the Company’s Class A common shares, effective through December 31, 2028 (the “Share Repurchase Program”). Repurchases under the Share Repurchase Program may be made in the open market, in privately negotiated transactions, or otherwise, with the amount and timing of repurchases to be determined at the Company’s discretion, depending on market conditions and corporate needs. Open market repurchases will be structured to occur in accordance with applicable federal securities laws, including within the pricing and volume requirements of Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The Company may also, from time to time, enter into Rule 10b5-1 plans to facilitate repurchases of its shares under such authorization. The Share Repurchase Program does not obligate the Company to acquire any particular number of Class A common shares, and the Share Repurchase Program may be modified, suspended, or terminated at any time at the discretion of the Company’s Board of Directors.

     


    Item 9.01. Financial Statements and Exhibits

     

    Exhibit
    No.
      

    Description

    10.1    Employment Agreement dated March 18, 2026
    10.2    Restrictive Covenant Agreement dated March 18, 2026
    10.3    Separation Agreement dated March 18, 2026
    99.1    Earnings release issued by the Company on March 18, 2026
    99.2    Earnings presentation issued by the Company on March 18, 2026
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    Signature

    Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: March 18, 2026   ACCELERANT HOLDINGS

     

        By:  

    /s/ Nancy Hasley

          Nancy Hasley
          Group General Counsel
    Get the next $ARX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARX

    DatePrice TargetRatingAnalyst
    12/4/2025$20.00Mkt Perform → Mkt Outperform
    Citizens JMP
    10/6/2025$19.50Neutral → Buy
    Goldman
    8/18/2025$35.00Overweight
    Piper Sandler
    8/18/2025Outperform
    William Blair
    8/18/2025$33.00Outperform
    Raymond James
    8/18/2025$34.00Outperform
    BMO Capital Markets
    8/18/2025$30.00Neutral
    Goldman
    8/18/2025Mkt Perform
    Citizens JMP
    More analyst ratings

    $ARX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Founder, Head of Distrib. Lee-Smith Christopher bought $197,240 worth of Class A Common Shares (14,700 units at $13.42), increasing direct ownership by 0.08% to 17,655,379 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    12/17/25 9:04:04 PM ET
    $ARX
    Specialty Insurers
    Finance

    Director Meriwether Karen Sue bought $7,951 worth of Class A Common Shares (542 units at $14.67), increasing direct ownership by 6% to 9,752 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    12/9/25 4:09:45 PM ET
    $ARX
    Specialty Insurers
    Finance

    Director Gaynor Samuel bought $100,774 worth of Class A Common Shares (7,500 units at $13.44) (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    11/20/25 4:17:43 PM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    SEC Filings

    View All

    SEC Form 10-K filed by Accelerant Holdings

    10-K - Accelerant Holdings (0001997350) (Filer)

    3/18/26 4:15:02 PM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Holdings filed SEC Form 8-K: Leadership Update

    8-K - Accelerant Holdings (0001997350) (Filer)

    3/18/26 4:10:36 PM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Holdings filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Accelerant Holdings (0001997350) (Filer)

    2/27/26 4:10:27 PM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accelerant Announces Fourth Quarter and Full Year 2025 Results

    Fourth Quarter & Full Year 2025 Results Exchange Written Premium of $1.09 billion grew 24% year-over-year during the fourth quarter and 35% for the full year 2025 Third-Party Direct Written Premium accounted for 40% of Exchange Written Premium volume, up from 21% in the prior year quarter Net income of $1 million, net income per diluted share of $0.00 for the fourth quarter Adjusted net income of $51 million (up 30% over the prior year), adjusted net income per diluted share of $0.23 for the fourth quarter Adjusted EBITDA of $71 million for the fourth quarter (up 52% over the prior year) and $68 million when excluding in-period investment gains (up 132% over the prior year).

    3/18/26 4:15:00 PM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Unaudited Preliminary Fourth Quarter and Full Year 2025 Financial Results

    Accelerant Holdings (NYSE:ARX), a data-driven company modernizing specialty insurance through the Accelerant Risk Exchange, today announced preliminary unaudited financial highlights for both the fourth quarter and year ended December 31, 2025. These estimates are preliminary and unaudited, and are subject to revision as Accelerant completes its fourth quarter and full-year 2025 financial closing process. Actual results may vary materially from today's announced results due to closing adjustments, subsequent events, or additional information identified prior to the issuance of Accelerant's audited financial statements. Accelerant's independent registered public accounting firm has not aud

    2/26/26 4:30:00 PM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Leadership Updates Across Legal and Investor Relations

    Cliff Jenks Named General Counsel and Corporate Secretary; Ray Iardella Will Join Company as Head of Investor Relations Beginning in Early March Accelerant (NYSE:ARX), a data-driven company modernizing specialty insurance through the Accelerant Risk Exchange, today announced the appointments of Cliff Jenks as General Counsel and Corporate Secretary and Ray Iardella as Head of Investor Relations. Jenks will oversee Accelerant's legal affairs and corporate governance, while Iardella will lead the company's engagement with the investment community. Cliff Jenks joins Accelerant with more than 20 years of experience in capital markets transactions, third party capital, M&A, investment transa

    2/24/26 4:00:00 PM ET
    $AJG
    $ARX
    $RGA
    Specialty Insurers
    Finance
    Life Insurance

    $ARX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Green Jay Michael

    4 - Accelerant Holdings (0001997350) (Issuer)

    3/18/26 7:24:02 PM ET
    $ARX
    Specialty Insurers
    Finance

    Chief Financial Officer Green Jay Michael covered exercise/tax liability with 200,637 units of Class A Common Shares, decreasing direct ownership by 14% to 1,254,214 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    2/4/26 4:05:48 PM ET
    $ARX
    Specialty Insurers
    Finance

    Co-Founder, Head of Distrib. Lee-Smith Christopher bought $197,240 worth of Class A Common Shares (14,700 units at $13.42), increasing direct ownership by 0.08% to 17,655,379 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    12/17/25 9:04:04 PM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Accelerant Holdings upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Accelerant Holdings from Mkt Perform to Mkt Outperform and set a new price target of $20.00

    12/4/25 8:19:30 AM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Holdings upgraded by Goldman with a new price target

    Goldman upgraded Accelerant Holdings from Neutral to Buy and set a new price target of $19.50

    10/6/25 8:19:36 AM ET
    $ARX
    Specialty Insurers
    Finance

    Piper Sandler initiated coverage on Accelerant Holdings with a new price target

    Piper Sandler initiated coverage of Accelerant Holdings with a rating of Overweight and set a new price target of $35.00

    8/18/25 8:53:58 AM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Financials

    Live finance-specific insights

    View All

    Accelerant Announces Unaudited Preliminary Fourth Quarter and Full Year 2025 Financial Results

    Accelerant Holdings (NYSE:ARX), a data-driven company modernizing specialty insurance through the Accelerant Risk Exchange, today announced preliminary unaudited financial highlights for both the fourth quarter and year ended December 31, 2025. These estimates are preliminary and unaudited, and are subject to revision as Accelerant completes its fourth quarter and full-year 2025 financial closing process. Actual results may vary materially from today's announced results due to closing adjustments, subsequent events, or additional information identified prior to the issuance of Accelerant's audited financial statements. Accelerant's independent registered public accounting firm has not aud

    2/26/26 4:30:00 PM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call

    Accelerant Holdings (NYSE:ARX), a leading technology company operating a data-driven risk exchange platform for the specialty insurance market, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the market opens on Thursday, March 19, 2026. Accelerant will host a webcast and conference call to discuss fourth quarter and full year financial results at 8:00 A.M. Eastern Time. Webcast and Conference Call Details When: March 19, 2026 at 8:00 A.M. Eastern Time. Webcast: A live webcast of the call can be accessed from the Investor Relations section of Accelerant's website at https://investor.accelerant.ai/. Following the

    2/9/26 8:00:00 AM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Third Quarter 2025 Results

    Exchange Written Premium of $1.043 billion grew 17% year-over-year and 39% on a year-to-date basis Net loss of $1.367 billion driven by non-cash and equity-neutral profits interest distribution expenses Adjusted net income of $79.8 million, up 320% over the prior year Net loss per basic and diluted share of $6.99, adjusted earnings per diluted share of $0.38 Adjusted EBITDA of $105.0 million and $66.3 million when excluding in-period investment gains (Adjusted EBITDA was up 302% year-over-year and 164% when excluding the investment gains) Additional key measures are presented below Accelerant Holdings (NYSE:ARX), a leading technology company operating a data-driven risk e

    11/12/25 4:15:00 PM ET
    $ARX
    Specialty Insurers
    Finance